Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012-2016.

Zah, Vladimir; Brookï¬eld, Rowe B; Imro, Martina; Tatovic, Simona; Pelivanovic, Jovana; Vukicevic, Djurdja

Zah, Vladimir; Brookï¬eld, Rowe B; Imro, Martina; Tatovic, Simona; Pelivanovic, Jovana; Vukicevic, Djurdja.

Afiliación

Zah V; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc, Mississauga, Ontario, Canada.
Brookï¬eld RB; Field Medical Affairs, Depomed, Inc, Newark, CA, USA.
Imro M; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc, Mississauga, Ontario, Canada.
Tatovic S; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc, Mississauga, Ontario, Canada.
Pelivanovic J; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc, Mississauga, Ontario, Canada.
Vukicevic D; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc, Mississauga, Ontario, Canada.

J Pain Res ; 12: 3037-3048, 2019.

Article en En | MEDLINE | ID: mdl-31819597

Palabras clave

administrative database; cost analysis; long-acting opioids; real-world evidence; subgroup analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Risk_factors_studies Idioma: En Revista: J Pain Res Año: 2019 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google